Renaissance Technologies’s Seelos Therapeutics, Inc. Common Stock SEEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-52
Closed -$206K 4493
2022
Q3
$206K Sell
52
-249
-83% -$979K ﹤0.01% 3372
2022
Q2
$785K Sell
301
-146
-33% -$380K ﹤0.01% 2868
2022
Q1
$1.44M Buy
+447
New +$1.92M ﹤0.01% 2471
2021
Q4
Sell
-41
Closed -$381K 4295
2021
Q3
$381K Sell
41
-74
-64% -$636K ﹤0.01% 2999
2021
Q2
$1.17M Buy
+115
New +$1.89M ﹤0.01% 2594
2021
Q1
Sell
-183
Closed -$1.11M 3797
2020
Q4
$1.11M Buy
183
+29
+19% +$114K ﹤0.01% 2446
2020
Q3
$554K Sell
154
-101
-40% -$363K ﹤0.01% 2777
2020
Q2
$989K Sell
255
-26
-9% -$86.3K ﹤0.01% 2544
2020
Q1
$529K Sell
281
-10
-3% -$37.2K ﹤0.01% 2738
2019
Q4
$1.5M Buy
291
+28
+11% +$107K ﹤0.01% 2451
2019
Q3
$927K Buy
263
+21
+9% +$127K ﹤0.01% 2633
2019
Q2
$2.04M Buy
242
+118
+95% +$1.24M ﹤0.01% 2319
2019
Q1
$1.6M Buy
124
+122
+6,100% +$1.97M ﹤0.01% 2434
2018
Q4
$36K Buy
+2
New +$69.5K ﹤0.01% 3305
2018
Q3
Hold
0
3320
2018
Q2
Sell
-2
Closed -$71K 3591
2018
Q1
$71K Buy
+2
New +$383K ﹤0.01% 3285
2015
Q1
Hold
0
-$54K 3385
2014
Q4
Hold
0
2865

Other funds holding SEEL

Renaissance Technologies's SEEL Position: Q4 2022 in Review

Renaissance Technologies sold out of Seelos Therapeutics, Inc. Common Stock (SEEL) in Q4 2022, closing a stake of 52 shares — an estimated $206K sold.

Renaissance Technologies first reported a position in SEEL in Q1 2018 and held it in 15 quarters. The position peaked at $2.04M in Q2 2019. 63 funds tracked by Wall St. Rank hold SEEL as of Q4 2022.

  • Renaissance Technologies reported no remaining Seelos Therapeutics, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Renaissance Technologies sold 52 Seelos Therapeutics, Inc. Common Stock shares in Q4 2022, an estimated $206K.
  • Renaissance Technologies first reported a position in Seelos Therapeutics, Inc. Common Stock in Q1 2018 and held it in 15 quarters.
  • Renaissance Technologies's Seelos Therapeutics, Inc. Common Stock position peaked at $2.04M in Q2 2019.
  • 63 funds tracked by Wall St. Rank held Seelos Therapeutics, Inc. Common Stock as of Q4 2022.

Based on Renaissance Technologies's 13F filing for Q4 2022, filed 13 Feb 2023.